一种新的α-synuclein G14R误解变体与非典型的神经病理特征有关
Christof Brücke1,2, Mohammed Al-Azzani3, Nagendran Ramalingam4
1Department of Neurology, Medical University Vienna, Austria.
medRxiv : the preprint server for health sciences
|October 14, 2024
概括
一种新的α-synuclein (aSyn) 突变 (G14R) 导致一种罕见的,遗传的帕金森病 (PD) 形式,具有独特的脑病理学. 这项研究探讨了G14R变异对aSyn结构和功能的影响,揭示了对PD病变发生的洞察力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 帕金森病 (PD) 是一种广泛的神经退行性疾病,罕见的单一性形式是由α-synuclein (SNCA) 基因突变引起的.
- 该SNCA基因编码的α-synuclein (aSyn),一个蛋白质的核心PD的发病因子,与已知的误解变体和基因乘法导致自体主导PD.
研究的目的:
- 为了研究在患有复杂神经退行性疾病的患者中发现的一种新型SNCA误解变异 (G14R).
- 描述与G14R aSyn变异相关的临床,遗传和神经病理特征.
- 阐明G14R突变对aSyn结构,聚合和细胞行为的功能后果.
主要方法:
- 整体外基因组测序 (WES) 用于SNCA变种的遗传识别.
- 对大脑组织进行神经病理学检查,以评估aSyn病理.
- 生物化学和生物物理分析 (NMR,thioflavin T,cryo-EM) 来研究aSyn结构和纤维化.
- 细胞测试用于研究G14R突变对aSyn聚合,膜协会和酸化的影响.
主要成果:
- 在一个患有泛性肌,勃拉迪基尼西亚, dystonia 和 apraxia 的患者中发现了一种新的异构性 SNCA G14R 变体.
- 神经病理学揭示了广泛的非典型aSyn病理与前叶退化 (FTLD) 和黑色退化,具有环状的神经元内含.
- 在细胞模型中,G14R突变改变了aSyn结构,减少了体外纤维化,促进了包容形成,改变了细胞模型中的酸化动态,表明家族成员的透不完全.
- 低温电子显微镜显示了G14R aSyn纤维的明显纤维状形态.
结论:
- 这种SNCA G14R变异与PD的独特临床和病理表型有关,可能会导致FTLD.
- 观察到的G14R aSyn的神经病理特征和功能性质支持蛋白质病变的菌株假设.
- 这项研究强调了帕金森病中遗传突变,蛋白质结构和疾病表现之间的复杂相互作用.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.2K
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
